A detailed history of Janus Henderson Group PLC transactions in Rx Sight, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 10,700 shares of RXST stock, worth $495,731. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,700
Previous 10,854 1.42%
Holding current value
$495,731
Previous $559,000 15.03%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$50.42 - $64.29 $7,764 - $9,900
-154 Reduced 1.42%
10,700 $643,000
Q1 2024

May 15, 2024

BUY
$35.51 - $57.92 $355 - $579
10 Added 0.09%
10,854 $559,000
Q4 2023

Feb 14, 2024

SELL
$20.91 - $40.9 $209 - $409
-10 Reduced 0.09%
10,844 $437,000
Q3 2023

Nov 14, 2023

BUY
$27.05 - $33.37 $541 - $667
20 Added 0.18%
10,854 $302,000
Q2 2023

Aug 14, 2023

BUY
$16.37 - $28.9 $177,352 - $313,102
10,834 New
10,834 $312,000

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $1.28B
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.